A structural characterization of the interaction between ab T cell receptors (TCR) and cognate peptide-MHC (pMHC) is central to understanding adaptive T cell mediated immunity. X-ray crystallography, although the source of much structural data, traditionally provides only a static snapshot of the protein. Given the emerging evidence for the important role of conformational dynamics in protein function, we interrogated 309 crystallographic structures of pMHC complexes using ensemble refinement, a technique that can extract dynamic information from the X-ray data.
Introduction ab T cell receptors (TCR) expressed on the surface of cytotoxic T cells engage endogenous peptide
antigens from infected or malignant cells that are displayed by major histocompatibility complex (MHC) proteins. Productive engagement of the TCR with the peptide-MHC (pMHC) leads to T cell activation and intracellular signal transduction via the CD3 signaling subunits. The TCR-pMHC molecular recognition event is thus key to the cell-mediated adaptive immune response and has been widely studied using X-ray crystallography. These studies have focused on the conformation of the peptide when bound to the MHC and the specific interactions between peptide and MHC side-chains, with or without bound TCR. While providing insights into the key features of TCRpMHC recognition, the detailed examination of a single static structure by X-ray crystallography reveals little about the conformational dynamics and degree of flexibility of the system in solution [1] [2] [3] . Given that protein flexibility is inextricably linked to protein function, consideration of protein dynamics is essential in order to achieve a full understanding of pMHC and TCR-pMHC binding.
Recent years have seen an increasing use of atomistic molecular dynamics (MD) simulations, which can probe the conformational flexibility of pMHC systems by computing iterative numerical solutions of Newton's equations of motion as the system evolves over time 4 . Unfortunately, the heavy computational demands of MD limits the technique to examination of relatively short time spans (usually less than a microsecond), and thereby excludes many larger motions that occur over longer, more biologically relevant timescales. Results of MD are also somewhat difficult to validate given the known imperfections of existing force fields [5] [6] [7] To circumvent some of these limitations, ensemble X-ray structure refinement can be employed 8 .
Instead of the usual practice of refining against a set of crystallographic reflections to produce a single protein structure, ensemble refinement combines the experimentally-derived reflection data with the results of a short, steered MD simulation to produce an ensemble of similar but distinct conformations of the protein. The structural diversity observed within the resulting ensemble thus provides information about the conformational flexibility of the protein, and in many cases improves the agreement between the structure and data as measured by the crystallographic free Rfactor (R free ). Notable recent applications of this method include an investigation of the conformational landscape of an insect carboxylesterase protein over the course of its catalytic cycle 9 , and the discovery of a self-inhibition mechanism mediating the transition between active and inactive protein of human factor D 10 . Therefore, this approach may offer significant new insights into protein function where crystallographic data already exists. Here we apply ensemble refinement to investigate protein dynamics at the TCR-pMHC interface.
Results
To acquire a sample of appropriate pMHC systems whose dynamics could be investigated using ensemble refinement, we first searched the Protein Data Bank (PDB) for pMHC complexes with a resolution of better than 3 Ångströms. Some of the resulting entries were rejected owing to lack of the necessary crystallographic reflection files, leaving 284 pMHC structures which were subjected to ensemble refinement as described in Methods. Each of these systems consisted of the heavy and light chains of the MHC molecule, the bound peptide, and also the a and b chains of the TCR when this was present. The ensemble refinement process takes as input a single crystallographic structure and returns as output an ensemble of several dozen structures that collectively fit the X-ray diffraction data roughly as well as the original single structure. Of all the systems we subjected to this process, we informally estimated that about half contained conformations noticeably different from the original PDB structures. It was therefore necessary to reduce this to a more manageable number of systems that we could subject to detailed structural analysis. First, in order to eliminate possible confounds we discarded all systems with bound ligands and missing peptide residues, leaving a total of 194 ensembles. Next, we ranked these systems according to the degree of conformational flexibility displayed by the peptide and MHC peptide-binding helices, as measured by the root mean square fluctuation (RMSF) of these residues calculated over the ensemble structures. We then focused our analysis only on published structures of human MHCs (human leukocyte antigens or HLA), and selected the top 30 most flexible MHC class I ensembles from the RMSF ranking. For each of these systems, we compared our results in detail to those reported in each original publication.
In comparing our ensemble results with the analyses reported in the original papers, we found it necessary to run an additional 25 ensembles to properly interpret our ensemble results in relation to structural and functional claims made in the literature. Of the 30 systems we examined in detail, we selected 12 illustrative cases in which our ensemble results provided the greatest functional insights pertinent to the claims made in the original literature. Given that in some cases the original study compared multiple pMHC systems, these 12 examples included a total of 20 distinct PDB structures, all of which are summarized in Table 1 . In our analysis of these systems, we highlight several new insights into TCR-pMHC engagement yielded by ensemble analysis compared to traditional approaches that consider only a single static structure. To supplement our ensemble results, five of the systems were selected for analysis in standard all-atom MD simulations, and the results compared to the corresponding ensembles. 
Conformational polymorphism and peptide variants
A common goal in studying HLA-A*02 systems is to determine the structural basis for differential TCR recognition of peptide or MHC variants, and the effect of such variations on T cell activation. 
Overinterpretation of static interactions
A differential T cell response is observed when HLA-B*27:05 and HLA-B*27:09 present the same pLMP2 EBV peptide. By inference, a differential T cell response to arthritogenic peptides may be the reason why HLA-B*27:05, but not HLA-B*27:09, is associated with spondyloarthropathies 15 .
To determine whether structural differences could account for the allele-specific disease association, Hülsmeyer et al 16 compared the structures of HLA-B*27:05 and HLA-B*27:09, each bound to a token peptide (m9). In their analysis they identify several subtle structural differences between the F-pocket regions of the two alleles, related to the exact position and orientation of P9-Lys, several of the surrounding MHC side-chains, and the network of water molecules mediating salt bridges between these residues ( Figure 3A) . They suggest such differences alter the dynamics of the HLA-B*27:09 F-pocket region and accordingly could affect TCR recognition. Our ensemble analysis, however, suggests a greater degree of flexibility of the F-pocket region of HLA-B*27:09 (PDB ID 1K5N), with all of the indicated side-chains displaying considerable variation in position and orientation ( Figure 3B ). Given this substantial intrinsic flexibility, the network of hydrogen bonds identified by the authors most likely exists only transiently. Our ensemble results therefore indicate that the difference in disease association of the two HLA-B*27 alleles is unlikely to be merely the result of the static structural differences reported in the study. Further work is necessary to determine whether the differences can instead be explained in terms of differing patterns of sidechain and peptide conformational variability.
A study by Rückert et al 17 also used X-ray crystallography to examine the association of HLA-B*27:05 with spondyloarthropathies, and hence investigate the potential role of molecular mimicry and T cell cross-reactivity in pathogenesis more generally . They determined the structure of HLA-B*27:05 bound to a glucagon-derived self-peptide (pGR) (PDB ID 2A83). pGR was selected based on its sequence similarity to pVIPR and pLMP2, which are respectively self and foreign peptides for which a proportion of T cells cross-react in ankylosing spondylitis patients compared to healthy controls. The aim was to determine if pGR could adopt the structurally similar and unusual conformation observed of both pVIPR and pLMP2 when bound to HLA-B*27:05, thereby indicating that cytotoxic T cell cross-reactivity may be due to molecular mimicry. Two pGR conformations were observed in the structure, and a network of contacts supporting those conformations reported ( Figure 3C ). Both pGR conformations were also observed in our ensemble, as well as a wide range of intermediate conformations and further variants ( Figure 3D ). We conducted MD on this system and found a very similar overall pattern of peptide flexibility to that seen in the ensembles ( Figure S1C and S1D), further emphasizing that many hydrogen-bonding networks in pMHC systems are not stable at physiological temperatures, but are in a constant state of dynamic flux.
In order to investigate the influence of MHC polymorphism on peptide conformation and the T cell 
Prominence of MHC-bound peptides in TCR recognition
Reiser et al 19 Overall our data highlights the danger in assuming that an observed difference between static pMHC and TCR-pMHC complexes is necessarily due to TCR binding, rather than the natural flexibility of each system. The traditional focus on static structures may have inadvertently had the effect of biasing analyses in favour of an induced fit mechanism, since the underlying conformational heterogeneity of the initial system which forms the basis for a conformational selection mechanism is overlooked. show that the P5 residue is highly flexible, adopting a range of conformations overlapping with that found in the TCR-bound form of the HLA-B*44:05 complex. The MHC α2-helices have been omitted.
Discussion
X-ray crystallography has played a considerable role in increasing our understanding of the structural basis of TCR-pMHC engagement, but is limited in that it provides only a static snapshot.
Therefore the role of conformational dynamics in TCR recognition of the pMHC has been largely overlooked, despite its important role in determining biological outcomes. Our study strongly emphasizes that a sizeable number of pMHC complexes exhibit considerable conformational flexibility that is not apparent in the published single-structure crystallographic model. Such dynamic variability, shown in both our ensemble and MD results, extends well beyond mere alternate side-chain rotamers or bond flips, and encompasses a vast range of motions including large-scale backbone movements and interconversion between substantively different peptide conformations. This result initially seems at odds with the relatively low B-factors reported in some of these systems. However, it is likely that B-factors substantially underestimate atomic motions, such that much of information on the flexibility and motions present in the molecule is lost in the refinement process 23, 24 . Our results corroborate these findings, and highlight the importance of using ensemble refinement techniques to more accurately gauge protein conformational flexibility.
Many contemporary TCR-pMHC structural studies attempt to determine the factors that influence TCR binding specificity or cross-reactivity by comparing the structures of two or more complexes and identifying similarities and differences. Thus, for instance, if a peptide adopts one conformation when bound to MHC alone and a different conformation when bound to MHC complexed with TCR, it is often inferred that this represents a change in conformation brought about by the binding of the TCR. However, as we have emphasized in the case studies discussed above, a baseline degree of structural heterogeneity must be expected in any protein system, resulting from the intrinsic flexibility of protein molecules. The precise position of backbone atoms, orientation of side chains, extent of hydrogen bonding networks, etc., is therefore expected to vary over time and between samples. Crystallographic structures are thus properly regarded as the result of random draws from the underlying distribution of protein conformational states. Observed structural differences between systems should therefore be compared in magnitude to the intrinsic structural variation within each system, to determine whether there is sufficient reason to justify claiming a significant difference between the systems. In principle this is much the same as statistical tests routinely applied in disciplines outside of structural biology, where a difference between two groups is only deemed significant if this inter-group difference is sufficiently greater than the intra-group variation.
Although it is possible to estimate coordinate error from the crystallographic data, no such method yet exists for statistical comparison of protein ensembles. The resulting failure to consider this baseline of structural heterogeneity has resulted in numerous false positive identifications of putative differences, and thereby hampered the growth in our understanding of MHC and T-cell function.
In addition to the question of whether two protein systems exhibit a structural difference that is significantly greater than background heterogeneity, there is the further question as to what is the most likely cause of this difference. In many structural studies there is a tendency to readily infer that, if an MHC-bound peptide changes conformation upon TCR ligation, then the TCR has induced this change in conformation. Though this is undoubtedly the case for some systems, in other systems it is likely that causation runs in the opposite direction, meaning that the reason the TCR has bound to the peptide is because the peptide has adopted that particular conformation. This distinction corresponds to the dispute between the 'induced fit' and 'conformational selection from existing equilibrium' models of protein interaction. As we noted previously, ensemble refinement provides a method uniquely suited to examine this question, since if the TCR-bound peptide conformation is already observed in the unbound pMHC ensemble, this constitutes at least prima facie evidence for a conformational selection mechanism 25 . Our ensemble results show that, at least for some peptide-MHC systems, there is a considerable degree of intrinsic flexibility, from which the TCR has considerable 'choice' in selecting a favorable form with which to bind. Recent work in support of these ideas has shown that conformational variability may facilitate several rounds of association and disassociation of peptides with MHC complexes, with low affinity peptides rapidly disassociating and thereby gradually establishing an equilibrium ensemble where a given MHC is only bound to its corresponding high affinity peptides 26 . Our results build upon these findings in providing further evidence of the importance of a structural ensemble-based approach in the study of MHC dynamics and affinity.
A third, related and important consideration when examining TCR-pMHC systems is that the intrinsic structural heterogeneity resulting from peptide and MHC flexibility need not always be simply random fluctuations about a single functional state. Rather, it is likely that in at least some cases different conformations of the system fulfil different functional purposes. As discussed in a number of the cases we considered, the flexibility of the system itself can play a role in determining binding specificity, for example through bond flips that alternate between bound and unbound peptide conformations. Such behaviors indicate that one cannot simply infer that because a peptide is observed in one particular conformation when crystallized bound to the TCR, this was the same conformation that the peptide adopted during the process of TCR recognition -it is possible that conformational changes may occur after the initial binding event. There may be one or more intermediates and/or transition states with subtly or considerably different conformations to that seen in the final complex, with the conformational variability an intrinsic part of the binding process. Peptide flexibility should therefore be considered from the outset as an essential functional aspect of the system when analyzing peptide, MHC and TCR binding dynamics.
Conclusions
Our analysis highlights the importance of analyzing the properties of protein ensembles rather than isolated structures. Examination of a variety of TCR-pMHC complexes suggests that reliance on single structures entails significant pitfalls for understanding the rules of productive TCR ligation, particularly for static interpretations involving fine details such as hydrogen-bonding networks and side chain orientation. Furthermore, our findings indicate that structural differences between the pMHC and TCR-pMHC conformations may be due to intrinsic flexibility rather than any change elicited by binding itself, and highlights the risk of false-positives in assuming that an observed difference between static pMHC and TCR-pMHC complexes is necessarily due to the binding process, rather than a reflection of the natural flexibility of each system. Broadly, our results imply that biological observations should be explained through the properties of ensembles rather than isolated structures, as these are less prone to observer bias. We propose that extracting dynamic information from X-ray data through the use of ensemble methods will not only mitigate these concerns but lead to a richer, dynamic understanding of TCR-pMHC interactions.
Materials and Methods

Computational resources
Calculations, modeling and simulations were performed on a range of computing resources:
ORCHARD 800 core x86 cluster (Monash University; X-ray ensemble refinement); Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE; atomistic MD).
Ensemble refinement
All atomic coordinates (.pdb) and crystallographic reflections (.mtz) files were sourced from the PDB_REDO server 27 . Ensembles were calculated with PHENIX 1.9-1692 28 by first passing each system through the ReadySet tool, and then using the Ensemble refinement tool with default parameters 8 . Ensemble analysis was performed using PyMOL version 1.3 29 and python scripts.
Atomic coordinates, modeling and graphics
In MD simulations, atomic coordinates were obtained from the following PDB entries: 1UXS, 2A83, 3H9H, 2LKN, and 3MRD. Structural representations were produced using PyMOL version 1.3 29 and VMD 1.9.1 30 . Trajectory manipulation and analysis was performed using MDTraj 31 and VMD 1.9.1 30 .
Molecular dynamics (MD) systems setup and simulation
Each protein, with protonation states appropriate for pH 7.0 32, 32 , was placed in a rectangular box with a border of at least 12 Å, explicitly solvated with TIP3P water 34 , counter-ions added, and parameterized using the AMBER ff14SB all-atom force field 35, 36, 37 . After an energy minimization stage and an equilibration stage, production simulations were performed in the NPT ensemble. Four independent replicates of each system were simulated for 500 ns each using NAMD 2.9 38 .
